13Gs

In a 13G filing on ValueVision Media Inc. (Nasdaq: VVTV) Great Oaks Capital Management disclosed a 2,059,073 share, or 6.4%, stake in the company. The firm held just 46,000 ValueVision shares at the quarter ended 3/31/09. A 13G indicates a "passive investment" above 5% but below 20%.

ValueVision Media, Inc., an integrated multi-channel retailer, markets, sells, and distributes its products directly to consumers through various forms of electronic media. The company's principal electronic media activity is its television home shopping business, but the company also markets an array of merchandise through its Internet retailing Web sites, ShopNBC.com and ShopNBC.TV

In a 13G filing after the close on Medicis Pharmaceutical Corp. (NYSE: MRX), D.E. Shaw disclosed a 3,136,350 share, or 5.3%, stake in the company. D.E. Shaw held 1,963,933 MRX shares at the quarter ended 3/31/09. A 13G indicates a "passive investment" above 5%.

Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

In a 13G filing on Sotheby's (NYSE: BID), Timothy Barakett's Atticus Capital LP disclosed a 3,584,110 share, or 5.4% stake. A 13G indicates a 'passive investment' over 5%. The firm did not show a stake BID at the quarter ended March 31, 2009.

Barakett's Atticus Capital hedge fund had a horrible 2008, but over the long run he has been viewed as a great stock picker.

It should also be noted, that Steve Cohen's SAC Capital owns an over 6% stake in BID.

Sotheby's, together with its subsidiaries, operates as an auctioneer of fine art, antiques and decorative art, and jewelry and collectibles primarily in the United States, the United Kingdom, the People's Republic of China, and France.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

In a 13G filing on Immucor Inc. (Nasdaq: BLUD), hedge fund JANA Partners disclosed a 5.5% stake, or 3,865,413 shares, in the company. The firm did not show a stake in BLUD at the quarter ended March 31, 2009. A 13G indicates a 'passive investment' above 5%.

Immucor, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of various reagents and automated systems. Its products are used primarily by hospitals, clinical laboratories, and blood banks.

In a 13G filing, billionaire Mark Cuban disclosed a 10.5% stake, 157,411 shares, in Reading International Inc. (NYSE: RDI). A 13G filing indicates a 'passive investment' above 5%.

Reading International, Inc., together with its subsidiaries, focuses on the development, ownership, and operation of multiplex cinemas, and retail and commercial real estate properties in the United States, Australia, and New Zealand.